Notably, the identification of known mesenchymal GBM drivers such as WWTR160 and FOSL131 by MGT1 and MGT4, respectively, denotes the specificity of the sLCRs and suggests that RAC1 could act as a driver of PMT, albeit with lower potency or cooperatively. Here, RAC1 is linked to glioblastoma.